Stereotaxis, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 7/24/2017
Contact Info
  • 4320 Forest Park Avenue
  • Suite 100
  • St. Louis, MO 63108

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0001289340
Fiscal Year End 12/31
OTC Marketplace OTCQX U.S.
Profile Data
SIC - Industry Classification 3845 - Electromedical equipment
Incorporated In: DE, USA
Year of Inc. 1990
Employees 122 a/o Jul 22, 2016
Company Officers/Contacts
David Fischel Acting CEO
Martin C. Stammer CFO, IR
David A. Giffin VP, Human Res.
Paul Brathwaite VP, R&D
Karen Duros General Counsel
Company Directors
David Fischel Chairman
David W. Benfer Independent Director, Nominating Committee Member
Joseph Kiani
Arun Menawat
Robert J Messey Independent Director, Audit Committee Member, Compensation Committee Member
Fred A Middleton Independent Director, Compensation Committee Member
Eric N Prystowsky Independent Director, Nominating Committee Member
Service Providers
Accounting/Auditing Firm
Ernst & Young LLP
5 Times Square
New York, NY, 10036-6530
United States
Securities Counsel

Not Available
Investor Relations Firm

Not Available
Company History
  • Sponsored for OTCQX by Bryan Cave LLP on 8/4/2016.
STXS Security Details
Share Structure
Market Value1 $17,786,729 a/o Nov 22, 2017
Authorized Shares 300,000,000 a/o Nov 07, 2017
Outstanding Shares 22,803,499 a/o Nov 07, 2017
-Restricted 977,374 a/o Nov 07, 2017
-Unrestricted 21,826,125 a/o Nov 07, 2017
Held at DTC 21,028,477 a/o Nov 07, 2017
Float Not Available
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
Broadridge Financial Solutions, Inc.
Shareholders of Record 386 a/o Mar 16, 2017
Short Selling Data
Short Interest 138,590 (-5%)
Oct 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security